Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2020 1
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers.
Lochrin SE, Turkbey B, Gasmi B, Schmidt K, Strope JD, Chau CH, Sissung TM, Price DK, Cordes L, Markolovic S, Wood BJ, Pinto PA, McKinney YL, Shih JH, Levy E, Madan R, Dahut W, Choyke PL, Merino M, Figg WD. Lochrin SE, et al. Sci Rep. 2021 Mar 11;11(1):5662. doi: 10.1038/s41598-021-84960-w. Sci Rep. 2021. PMID: 33707581 Free PMC article. Clinical Trial.
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer.
Madan RA, Karzai F, Donahue RN, Al-Harthy M, Bilusic M, Rosner II, Singh H, Arlen PM, Theoret MR, Marté JL, Cordes L, Couvillon A, Hankin A, Williams M, Owens H, Lochrin SE, Chau CH, Steinberg S, Figg WD, Dahut W, Schlom J, Gulley JL. Madan RA, et al. Among authors: lochrin se. J Immunother Cancer. 2021 Mar;9(3):e001556. doi: 10.1136/jitc-2020-001556. J Immunother Cancer. 2021. PMID: 33664086 Free PMC article. Clinical Trial.